XIENCE V: SPIRIT WOMEN Sub-study
- Conditions
- Coronary Artery StenosisCoronary ArteriosclerosisCoronary Artery DiseaseCoronary Artery RestenosisTotal Coronary OcclusionStent ThrombosisVascular DiseaseMyocardial Ischemia
- Interventions
- Device: CYPHER SELECTDevice: XIENCE V®/ XIENCE PRIME™
- First Posted Date
- 2010-08-16
- Last Posted Date
- 2012-08-07
- Lead Sponsor
- Abbott Medical Devices
- Target Recruit Count
- 455
- Registration Number
- NCT01182428
- Locations
- 🇵🇱
Institute of Cardiology, Warsaw, Poland
🇮🇹Ospedale Cisanello, Pisa, Italy
🇩🇪Kardiologische Klinik Herz- und Diabeteszentrum, Bad Oeynhausen, Germany
QuickFlex Micro Left Ventricular Lead Post Approval Study
- Conditions
- Heart Failure
- First Posted Date
- 2010-08-11
- Last Posted Date
- 2019-08-12
- Lead Sponsor
- Abbott Medical Devices
- Target Recruit Count
- 1930
- Registration Number
- NCT01179477
- Locations
- 🇺🇸
Claudio Bonometti MD, Inc, Santa Barbara, California, United States
🇺🇸Heart Center Research, LLC., Huntsville, Alabama, United States
🇺🇸Alaska Heart Institute, Anchorage, Alaska, United States
XIENCE V Everolimus Eluting Coronary Stent System (EECSS) China: Post-Approval Randomized Control Trial (RCT)
- Conditions
- Coronary RestenosisThrombosis (Stent Thrombosis)Vascular DiseaseCoronary DiseaseCoronary OcclusionMyocardial IschemiaCoronary Artery StenosisCoronary Artery Disease
- Interventions
- Device: CYPHER SELECT PLUS SECSSDevice: XIENCE V EECSS
- First Posted Date
- 2010-08-10
- Last Posted Date
- 2016-08-24
- Lead Sponsor
- Abbott Medical Devices
- Target Recruit Count
- 546
- Registration Number
- NCT01178268
- Locations
- 🇨🇳
Fu Wai Hospital, Beijing, China
🇨🇳Authorized Representative in China Guidant International Trading (Shanghai) Co., Ltd., Shanghai, China
SPIRIT V: A Clinical Evaluation of the XIENCE V® Everolimus Eluting Coronary Stent System in the Treatment of Patients With de Novo Coronary Artery Lesions (Diabetic Sub-Study)
- Conditions
- Coronary Artery DiseaseCoronary DiseaseCoronary Restenosis
- Interventions
- Device: TAXUS® Liberté™Device: XIENCE V® EECSS
- First Posted Date
- 2010-07-29
- Last Posted Date
- 2016-06-27
- Lead Sponsor
- Abbott Medical Devices
- Target Recruit Count
- 324
- Registration Number
- NCT01171820
- Locations
- 🇩🇪
Herzzentrum Siegburg GmbH, Siegburg, Germany
🇫🇷CHU Lille - Hôpital Cardiologique, Lille, France
🇩🇪Herzzentrum, Bernau, Germany
QuickOpt Chronic Study
- Conditions
- Heart Failure
- Interventions
- Device: Optimization using echocardiographyDevice: Cardiac Resynchronization Therapy
- First Posted Date
- 2010-07-29
- Last Posted Date
- 2019-10-08
- Lead Sponsor
- Abbott Medical Devices
- Target Recruit Count
- 400
- Registration Number
- NCT01172067
- Locations
- 🇨🇳
Fuwai Hospital, Beijing, Beijing, China
CentriMag Ventricular Assist System in Treating Failure-to-Wean From Cardiopulmonary Bypass for Pediatric Patients
- Conditions
- Heart Failure
- Interventions
- Device: CentriMag Ventricular Assist System
- First Posted Date
- 2010-07-29
- Last Posted Date
- 2022-06-24
- Lead Sponsor
- Abbott Medical Devices
- Registration Number
- NCT01171950
Data Registry Following Patients Using Supera Stent in the Femoral Arteries
- Conditions
- Peripheral Artery DiseaseFemoropopliteal Artery StenosisPeripheral Vascular Disease
- Interventions
- Device: SUPERA Interwoven self-expanding nitinol stent
- First Posted Date
- 2010-07-01
- Last Posted Date
- 2017-09-19
- Lead Sponsor
- Abbott Medical Devices
- Target Recruit Count
- 200
- Registration Number
- NCT01154751
- Locations
- 🇩🇪
Heart Center Leipzig/Park Hospital, Leipzig, Germany
🇩🇪Kathlisches Klinikum Mainz, Mainz, Germany
🇩🇪Herzzentrum Abteilung fur Angiologie, Bad Krozingen, Germany
FAME II - Fractional Flow Reserve (FFR) Guided Percutaneous Coronary Intervention (PCI) Plus Optimal Medical Treatment (OMT) Verses OMT
- Conditions
- Coronary Artery Disease
- Interventions
- Other: Stenting plus OMTOther: Standard of careOther: OMT
- First Posted Date
- 2010-05-28
- Last Posted Date
- 2019-09-16
- Lead Sponsor
- Abbott Medical Devices
- Target Recruit Count
- 1170
- Registration Number
- NCT01132495
- Locations
- 🇺🇸
VA Palo Alto, Palo Alto, California, United States
🇺🇸Stanford University Medical Center, Stanford, California, United States
🇨🇿Masaryk University and University Hospital Brno, Brno, Czechia
Left Atrial Pressure Monitoring to Optimize Heart Failure Therapy
- Conditions
- Heart Failure
- Interventions
- Device: Left Atrial Pressure Monitoring SystemDevice: Patient Advisory Module
- First Posted Date
- 2010-05-12
- Last Posted Date
- 2023-07-21
- Lead Sponsor
- Abbott Medical Devices
- Target Recruit Count
- 486
- Registration Number
- NCT01121107
- Locations
- 🇺🇸
Pacific Heart Institute, Santa Monica, California, United States
🇺🇸Northeast Ohio Cardiovascular, Akron, Ohio, United States
🇺🇸The Emory Clinic - Crawford Long Hospital, Atlanta, Georgia, United States
XIENCE V® Everolimus Eluting Coronary Stent System USA Post-Approval Study (XIENCE V® USA Long Term Follow-up Cohort)
- Conditions
- Chronic Coronary OcclusionCoronary Artery StenosisCoronary DiseaseCoronary RestenosisMyocardial IschemiaCoronary Artery DiseaseVascular Disease
- Interventions
- Device: XIENCE V® EECSS
- First Posted Date
- 2010-05-10
- Last Posted Date
- 2015-06-22
- Lead Sponsor
- Abbott Medical Devices
- Target Recruit Count
- 5034
- Registration Number
- NCT01120379
- Locations
- 🇺🇸
Abbott Vascular, Santa Clara, California, United States